These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 15022293)
1. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors. Tzika AA; Astrakas LG; Zarifi MK; Zurakowski D; Poussaint TY; Goumnerova L; Tarbell NJ; Black PM Cancer; 2004 Mar; 100(6):1246-56. PubMed ID: 15022293 [TBL] [Abstract][Full Text] [Related]
2. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Astrakas LG; Zurakowski D; Tzika AA; Zarifi MK; Anthony DC; De Girolami U; Tarbell NJ; Black PM Clin Cancer Res; 2004 Dec; 10(24):8220-8. PubMed ID: 15623597 [TBL] [Abstract][Full Text] [Related]
3. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors]. Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499 [TBL] [Abstract][Full Text] [Related]
4. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Marcus KJ; Astrakas LG; Zurakowski D; Zarifi MK; Mintzopoulos D; Poussaint TY; Anthony DC; De Girolami U; Black PM; Tarbell NJ; Tzika AA Int J Oncol; 2007 Mar; 30(3):651-7. PubMed ID: 17273766 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898 [TBL] [Abstract][Full Text] [Related]
7. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Zeng QS; Li CF; Liu H; Zhen JH; Feng DC Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287 [TBL] [Abstract][Full Text] [Related]
8. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy. Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values. Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403 [TBL] [Abstract][Full Text] [Related]
10. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis. Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882 [TBL] [Abstract][Full Text] [Related]
12. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling. Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478 [TBL] [Abstract][Full Text] [Related]
13. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III. Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995 [TBL] [Abstract][Full Text] [Related]
14. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions. Smith EA; Carlos RC; Junck LR; Tsien CI; Elias A; Sundgren PC AJR Am J Roentgenol; 2009 Feb; 192(2):W45-52. PubMed ID: 19155380 [TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725 [TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats. Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181 [TBL] [Abstract][Full Text] [Related]
17. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395 [TBL] [Abstract][Full Text] [Related]
18. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615 [TBL] [Abstract][Full Text] [Related]
19. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation. Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178 [TBL] [Abstract][Full Text] [Related]
20. Clinical and imaging study of human immunodeficiency virus-1-infected youth receiving highly active antiretroviral therapy: pilot study using magnetic resonance spectroscopy. Gabis L; Belman A; Huang W; Milazzo M; Nachman S J Child Neurol; 2006 Jun; 21(6):486-90. PubMed ID: 16948932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]